在非酒精性脂肪肝肝炎-肝细胞癌转化中的重要基因的识别和分析:生物信息学分析和机器学习方法

相关实验视频

Updated: Jun 16, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Qiyi Yu1, Yidong Zhang1, Jiaping Ni1

  • 1Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.

Molecular immunology
|August 14, 2024
PubMed
概括

研究人员确定了五个关键基因 (ME1,TP53I3,SOCS2,GADD45G,CYP7A1) 驱动非酒精性脂肪肝炎 (NASH) 到肝癌 (HCC) 的进展. TP53I3和SOCS2在诊断和治疗NASH相关的HCC方面特别有前途.

关键词:
在NASH-HCC转换过程中.生物信息学是一种生物信息学.大量的-seqq.诊断模型 诊断模型 诊断模型这就是 scRNA-seqq.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...